• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮祖细胞:其旁分泌因子在心血管治疗中的最新发展。

Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy.

机构信息

Department of Cardiology, Biomedical Research (Therapy) Center, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

J Cardiovasc Pharmacol. 2012 Apr;59(4):387-96. doi: 10.1097/FJC.0b013e3182440338.

DOI:10.1097/FJC.0b013e3182440338
PMID:22157259
Abstract

Endothelial progenitor cells were initially considered to radically alter the concepts of adult tissue angiogenesis for their contribution of incorporation into new blood vessels. Nevertheless, controversy arises over their mechanism of action due to rare cell population and decreased number and impaired activity under pathological changes. Recent studies show that endothelial progenitor cells also function in a paracrine manner by secreting multiple cytokines and growth factors, but the beneficial paracrine signals remain partially unidentified. In this review, we provide an overview of varieties and signal pathways of factors secreted by endothelial progenitor cells and further present the prospect of new ways to encourage cardiovascular protection such as neovascularization, reendothelialization of larger vessels, and myocardial remodeling based on the paracrine factors.

摘要

内皮祖细胞最初被认为通过整合到新血管中来彻底改变成人组织血管生成的概念。然而,由于其细胞数量稀少,数量减少和活性受损,它们的作用机制引起了争议。最近的研究表明,内皮祖细胞还通过分泌多种细胞因子和生长因子发挥旁分泌作用,但是有益的旁分泌信号仍部分未知。在这篇综述中,我们提供了内皮祖细胞分泌的因子的种类和信号通路的概述,并进一步根据旁分泌因子提出了鼓励心血管保护的新方法的前景,例如新血管生成,大血管的再内皮化和心肌重构。

相似文献

1
Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy.内皮祖细胞:其旁分泌因子在心血管治疗中的最新发展。
J Cardiovasc Pharmacol. 2012 Apr;59(4):387-96. doi: 10.1097/FJC.0b013e3182440338.
2
Endothelial progenitor cell-based neovascularization: implications for therapy.基于内皮祖细胞的新生血管形成:对治疗的意义。
Trends Mol Med. 2009 Apr;15(4):180-9. doi: 10.1016/j.molmed.2009.02.001. Epub 2009 Mar 18.
3
Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting.CD34 祖细胞对血管生成内皮芽生的旁分泌作用。
Int J Cardiol. 2010 Mar 4;139(2):134-41. doi: 10.1016/j.ijcard.2008.10.009. Epub 2008 Nov 12.
4
Endothelial progenitor cells as a new agent contributing to vascular repair.内皮祖细胞作为促进血管修复的一种新因子。
Arch Immunol Ther Exp (Warsz). 2007 Jul-Aug;55(4):247-59. doi: 10.1007/s00005-007-0027-5. Epub 2007 Jul 23.
5
Endothelial progenitor cells in cardiovascular disorders.心血管疾病中的内皮祖细胞。
J Am Coll Cardiol. 2007 Feb 20;49(7):741-52. doi: 10.1016/j.jacc.2006.09.050.
6
Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.内皮祖细胞移植治疗心血管疾病。
Cell Transplant. 2009;18(9):1003-12. doi: 10.3727/096368909X12483162196683. Epub 2009 Jun 22.
7
Stem cells in tumor angiogenesis.肿瘤血管生成中的干细胞。
J Mol Cell Cardiol. 2011 Feb;50(2):290-5. doi: 10.1016/j.yjmcc.2010.10.024. Epub 2010 Nov 1.
8
Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.内皮祖细胞释放的可溶性因子促进内皮细胞和心脏驻留祖细胞的迁移。
J Mol Cell Cardiol. 2005 Nov;39(5):733-42. doi: 10.1016/j.yjmcc.2005.07.003. Epub 2005 Sep 29.
9
Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases.早期内皮祖细胞与晚期迁移内皮细胞混合移植的协同血管生成:血管生成细胞因子和基质金属蛋白酶的作用
Circulation. 2005 Sep 13;112(11):1618-27. doi: 10.1161/CIRCULATIONAHA.104.503433. Epub 2005 Sep 6.
10
Enhancement of new vessel formation by angiopoietin-2/Tie2 signaling in endothelial progenitor cells: a new hope for future therapy?血管生成素-2/Tie2信号通路增强内皮祖细胞中新血管形成:未来治疗的新希望?
Cardiovasc Res. 2006 Dec 1;72(3):359-60. doi: 10.1016/j.cardiores.2006.09.017. Epub 2006 Sep 29.

引用本文的文献

1
Research Progress on Cardiac Tissue Construction of Mesenchymal Stem Cells for Myocardial Infarction.间充质干细胞用于心肌梗死心脏组织构建的研究进展
Curr Stem Cell Res Ther. 2024;19(7):942-958. doi: 10.2174/1574888X18666230823091017.
2
Bioactive extracellular matrix scaffolds engineered with proangiogenic proteoglycan mimetics and loaded with endothelial progenitor cells promote neovascularization and diabetic wound healing.用促血管生成蛋白聚糖模拟物构建并负载内皮祖细胞的生物活性细胞外基质支架可促进新生血管形成和糖尿病伤口愈合。
Bioact Mater. 2021 Sep 11;10:460-473. doi: 10.1016/j.bioactmat.2021.08.017. eCollection 2022 Apr.
3
Construction and a preliminary study of paracrine effect of bone marrow-derived endothelial progenitor cell sheet.
构建骨髓源内皮祖细胞片的旁分泌作用及其初步研究。
Cell Tissue Bank. 2022 Mar;23(1):185-197. doi: 10.1007/s10561-021-09932-w. Epub 2021 May 30.
4
VEGF and Ang-1 promotes endothelial progenitor cells homing in the rat model of renal ischemia and reperfusion injury.血管内皮生长因子(VEGF)和血管生成素-1(Ang-1)促进肾缺血再灌注损伤大鼠模型中内皮祖细胞归巢。
Int J Clin Exp Pathol. 2017 Dec 1;10(12):11896-11908. eCollection 2017.
5
Exercise and Cardiovascular Progenitor Cells.运动与心血管祖细胞。
Compr Physiol. 2019 Mar 14;9(2):767-797. doi: 10.1002/cphy.c180030.
6
The anti-microbial peptide SR-0379 stimulates human endothelial progenitor cell-mediated repair of peripheral artery diseases.抗菌肽 SR-0379 可刺激人内皮祖细胞修复外周动脉疾病。
BMB Rep. 2017 Oct;50(10):504-509. doi: 10.5483/bmbrep.2017.50.10.043.
7
Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality.用于动脉修复的祖细胞:迈向治疗现实的渐进式进展。
Stem Cells Int. 2017;2017:8270498. doi: 10.1155/2017/8270498. Epub 2017 Jan 23.
8
Left ventricular mass and progenitor cells in chronic heart failure patients.慢性心力衰竭患者的左心室质量与祖细胞
Intern Emerg Med. 2015 Apr;10(3):329-35. doi: 10.1007/s11739-014-1149-5. Epub 2014 Nov 12.
9
Strategies affording prevascularized cell-based constructs for myocardial tissue engineering.为心肌组织工程提供预血管化细胞构建体的策略。
Stem Cells Int. 2014;2014:434169. doi: 10.1155/2014/434169. Epub 2014 Jan 5.
10
Ischemic preconditioning increases endothelial progenitor cell number to attenuate partial nephrectomy-induced ischemia/reperfusion injury.缺血预处理可增加内皮祖细胞数量,减轻部分肾切除术诱导的缺血/再灌注损伤。
PLoS One. 2013;8(1):e55389. doi: 10.1371/journal.pone.0055389. Epub 2013 Jan 31.